Next Article in Journal
Ca2+/Sr2+ Selectivity in Calcium-Sensing Receptor (CaSR): Implications for Strontium’s Anti-Osteoporosis Effect
Next Article in Special Issue
Preservation of Mitochondrial Coupling and Renal Function by Controlled Oxygenated Rewarming of Porcine Kidney Grafts
Previous Article in Journal
The Role of Endogenous Metal Nanoparticles in Biological Systems
Previous Article in Special Issue
Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 11
Issue 11
10.3390/biom11111575
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism

by
Liang-Jun Yan
* and
Daniel C. Allen
Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA
*
Author to whom correspondence should be addressed.
Biomolecules 2021, 11(11), 1575; https://doi.org/10.3390/biom11111575
Submission received: 16 September 2021 / Revised: 15 October 2021 / Accepted: 20 October 2021 / Published: 23 October 2021
(This article belongs to the Special Issue Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease)
Browse Figures
Versions Notes

Abstract

:
Cadmium is a nonessential metal that has heavily polluted the environment due to human activities. It can be absorbed into the human body via the gastrointestinal tract, respiratory tract, and the skin, and can cause chronic damage to the kidneys. The main site where cadmium accumulates and causes damage within the nephrons is the proximal tubule. This accumulation can induce dysfunction of the mitochondrial electron transport chain, leading to electron leakage and production of reactive oxygen species (ROS). Cadmium may also impair the function of NADPH oxidase, resulting in another source of ROS. These ROS together can cause oxidative damage to DNA, proteins, and lipids, triggering epithelial cell death and a decline in kidney function. In this article, we also reviewed evidence that the antioxidant power of plant extracts, herbal medicines, and pharmacological agents could ameliorate cadmium-induced kidney injury. Finally, a model of cadmium-induced kidney injury, centering on the notion that oxidative damage is a unifying mechanism of cadmium renal toxicity, is also presented. Given that cadmium exposure is inevitable, further studies using animal models are warranted for a detailed understanding of the mechanism underlying cadmium induced ROS production, and for the identification of more therapeutic targets.

1. Introduction

The kidney is a vital organ that performs critical physiological functions by actively filtering excess fluid and secreting waste products including urea, uric acid, and creatinine [1,2]. It is through the process of filtration and reabsorption that the kidneys maintain homeostasis of water, acid-base and, electrolytes [3]. Moreover, the kidney also secretes hormones that participate in the control and regulation of hemodynamics, red blood cell production, and vitamin D maturation [3]. Under abnormal conditions such as fasting and insulin resistance, the kidney can also make glucose via the gluconeogenic pathway [4,5,6] using noncarbohydrate precursors such as pyruvate, alanine, lactate, and glycerol [7].
The kidney is also vulnerable to injuries caused by numerous challenges such as ischemia [8,9,10,11,12], drug toxicity [13,14,15,16,17,18,19], environmental heavy metal exposure [20,21,22,23,24,25,26,27], hypertension [28,29,30], immune injury [31,32], and diabetes [33,34,35,36]. In terms of environmental risk factors, human kidney disease caused by environmental pollutants and occupational-linked toxins is a major public health issue [37]. Cadmium is a toxic heavy metal mainly derived from chemical stabilizers, pigments, nickel-cadmium batteries, and metal coatings and alloys [38]. It is also a toxic element in cigarettes [38]. Accordingly, contaminated soil, air, drinking water, food chains [39,40], and cigarettes, as well as children’s plastic toys [41], are the major sources of human cadmium exposure. Numerous studies focusing on cadmium toxicity have established that the kidney is a primary organ site for cadmium accumulation [42,43]. Indeed, cadmium exposure has been tightly associated with renal dysfunction and kidney damage, causing polyuria and proteinuria [23,24]. The proximal tubule is the major site of cadmium deposition, accumulation, and damage because of the development of proximal tubular epithelial cell hypertrophy with occurrence of polyuria and proteinuria [44,45,46]. Therefore, it is important to counteract cadmium-induced kidney injury to safeguard kidney function.

2. Cadmium Absorption, Transportation, and Accumulation in the Kidney

Cadmium has a high affinity toward thiol groups and can selectively form complexes with proteins and peptides whose cysteine residues are available for cadmium binding [47,48]. After ingestion of cadmium-contaminated water, food, and/or cigarette smoking, cadmium can be absorbed into circulation via the gastrointestinal tract, respiratory tract, or the skin [49,50,51]. Once in the blood, cadmium binds to albumin and other cysteine-containing proteins and peptides such as glutathione [37] and gets transported via many avenues to the liver [37] whereby the heavy metal is then released and induces the expression of metallothionein that then binds tightly to cadmium [52,53]. This binding serves the purpose of detoxification as the cadmium-metallothionein complex is usually considered nontoxic [54]. The cadmium-metallothionein complex can be released into the bloodstream and is then filtered at the glomerulus and reabsorbed by the proximal tubular epithelial cells [55]. This is followed by release of cadmium from the degradation of the cadmium-metallothionein complex [55]. The free form of cadmium in the proximal tubular region of the nephron can then bind to pre-existing renal metallothionein and induce further renal expression of metallothionein [50]. When renal metallothionein is exhausted [56,57], the nonmetallothionein bound cadmium accumulates and induces nephrotoxicity [49,50,51,58,59], primarily in the proximal tubular region (Figure 1) via generation of oxygen free radicals [60,61,62]. As up to 50% of the body’s cadmium pool can deposit in the kidney [37] and the half-life of cadmium in the kidney is approximately 45 years [63,64,65,66,67], cadmium-caused renal toxicity can pose a major threat to human health, particularly in countries where environmental control and regulation are lacking. It should be noted that while the binding of cadmium to metallothionein is a well-established mechanism, other thiol-containing proteins and peptides such as albumin and glutathione can also bind cadmium, leading to functional impairment of these cadmium bound target proteins and peptides [50].

3. Cadmium-Induced Animal Models of Kidney Injury

Given the fact that human cadmium exposure is a chronic process at a very low level, any investigation of cadmium renal toxicity would require many years of monitoring and follow-up studies. Therefore, animal models using mice or rats have been widely used to replicate the pathophysiological mechanisms of cadmium renal toxicity [39,40,42,68]. In numerous cases, high doses of cadmium were applied in these animal models to shorten the duration of the studies and facilitate the process of obtaining insights into the mechanisms of cadmium renal toxicity. As mentioned above, studies using rodent models as well as results from human subjects have established that the primary target of cadmium in the nephron is the proximal tubule, whereby cadmium causes overall dysfunction of the epithelial cells [51,69,70], resulting in polyuria and proteinuria [50,51]. There is also an increase in urinary excretion of amino acids, glucose, and electrolytes such as Na+. K+, and Ca2+ [50,51]. Increasing evidence also indicates that a variety of risk factors such as aging [71], malnutrition [72], obesity [73,74,75], and diabetes [27,76] can further superimpose on cadmium renal toxicity and aggravate cadmium-induced renal dysfunction.
It should be stressed that in animal model studies of cadmium renal injury, a variety of doses, routes, and duration of exposures have been performed. The purpose of all these approaches is to try to replicate or recapitulate the toxico-kinetics and underlying mechanisms of long-term, low-level exposure that commonly occur in humans [50].

4. Mechanisms of Cadmium-Induced Renal Toxicity

What is the proposed mechanism of cadmium-induced kidney injury? Based on numerous studies, all injurious pathways converge on ROS production and culminate in oxidative stress [77,78,79,80,81], which suggests that oxidative damage is a unifying mechanism of cadmium-induced renal toxicity and injury. We also think that the major sources of ROS causing oxidative damage in this context are mitochondria and NADPH oxidase, described as follows.

5. Sources of Reactive Oxygen Species

5.1. Mitochondria

Mitochondria are well known as the intracellular site of ROS production [82,83,84,85]. Among the electron transport chain components complexes I, II and III have all been established as major sites of ROS production [86,87,88,89]. These sites are not perfect even under normal conditions and can leak electrons out of the transport chain [90,91] (Figure 2). The leaked electrons can then partially reduce oxygen to form superoxide anion, which is the precursor of all other reactive oxygen species including H2O2, hydroxyl radical, and peroxynitrite [92,93] (Figure 3). Additionally, dihydrolipoamide dehydrogenase involved enzyme complexes such as pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and branched chain amino acid dehydrogenase can also produce superoxide anion in a variety of experimental and pathological conditions [94,95,96,97].

5.2. NADPH Oxidase

NADPH oxidase (NOX) can generate superoxide anion using NADPH as its reducing agent [99]. So far, seven NOXs have been identified (NOX 1-5, Duox1 and DuoX2) [99]. These isoforms differ in many aspects including catalytic oxidase subunit, tissue distribution, intra-cellular location, and mechanisms of regulation [100,101]. All NOXs are composed of multiple subunits. Upon stimulation, these subunits will come together and assemble to form a membrane-associated complex to generate superoxide at the expense of NADPH [102]. Figure 4 shows a representative diagram of NOX assembly upon stimulation whereby the major site of ROS production is the gp91phox subunit with other proteins being the ancillary units required for the regulation and functioning of the whole enzyme complex. It should be noted that Figure 4 only shows the assembly of NOX2. The structural and compositional variations of other NOX isoforms [103] and their potential interaction with cadmium may also play a role in cadmium induced renal toxicity. Under normal conditions, these NOXs function in a beneficial way by regulating kidney metabolism and homeostasis including glucose transport, gluconeogenesis, renal hemodynamics, and electrolyte transport and balance [99]. Under pathophysiological conditions, these NOXs, in particular NOX2 and NOX4 in the kidney, can overgenerate ROS that are damaging to cellular components including DNA, proteins, and lipids, causing cell death and kidney injury [99,104,105,106]. It has been reported that cadmium exposure can increase the expression of NOX1 subunits, leading to increased ROS production from the enzyme [107]. Nevertheless, it is not known exactly which subunit in the NADPH oxidase physically interacts with cadmium at the present time. It should be noted that xanthine oxidase [108,109] and nitric oxide synthase [110,111,112], although not a major source of ROS in the kidney, may also contribute to renal oxidative stress under a variety of pathological and experimental conditions including cadmium exposure. It should also be pointed out that comprehensive evaluations of the roles of NADPH oxidases, xanthine oxidase, and nitric oxide synthase in cadmium-induced kidney injury remain to be conducted.

6. Effects of Cadmium on Mitochondrial Function

Cadmium can enter mitochondria and accumulate therein [113,114]. This is likely facilitated by mitochondrial membrane channels, and solute molecule carriers and receptors [114]. Once inside the mitochondria, cadmium can bind thiol-containing proteins and impair the corresponding protein function [80]. Studies have demonstrated that upon exposure to cadmium, kidney mitochondria displayed deformation, swelling, and vaculation, concurrent with increased SOD1 expression and decreased SOD2 and catalase expression [115]. Additionally, the anti-apoptotic protein BCL-2 was also found decreased by cadmium exposure [115]; so was the ratio between reduced glutathione and oxidized glutathione [60]. All these could be a generalized cadmium mitochondrial toxicity and the ultimate outcome would be reflected by overproduction of mitochondrial ROS, disruption of mitochondrial metabolic pathways, and impairment of mitochondrial pores, membrane channels and transporters [80]. It has been reported that complex II and complex III may be the major sites impaired by cadmium in the nephrons [98] while the effects of cadmium on proximal tubular mitochondrial complex I (NADH-ubiquinone oxidoreductase) remain unclear. Disruption of all these processes by cadmium would increase mitochondrial ROS production and eventually lead to cell death and kidney injury [80,114,116,117,118,119]. An outline of cadmium induced ROS production, oxidative damage to macromolecules, cell death, and kidney injury is shown in Figure 5, highlighting the concept that oxidative damage is a unifying mechanism of cadmium-induced kidney injury.

7. Counteracting Effects of Natural Products, Chemicals and Pharmacological Agents on Cadmium-Induced Kidney Injury

In further support of the notion that oxidative stress and oxidative damage are the universal mechanisms underlying renal toxicity by cadmium, we herein tabulate evidence that numerous natural products such as plant extracts and herbal medicines have been used to counteract the oxidative, deleterious effects of cadmium on the kidney. Many of these studies used cadmium-induced animal models of kidney injury as a platform [120]. Table 1 selectively shows some of the reported plant extracts and herbs as well as exogenous chemicals and pharmacological agents that can attenuate cadmium-induced oxidative stress involved in kidney injury. Additionally, many of these approaches can also induce the activation of endogenous cellular defense systems such as Nrf2, superoxide dismutase, glutathione peroxidase, and catalase [74,121,122,123,124]. Some studies using kidney cell lines such as HEK293 are also included in the table. It should be pointed out that among all the compounds and chemicals listed in Table 1, it is very difficult to identify which one would be the most efficient in terms of combating confirmed cadmium-induced kidney injury as cross examination and comparison of these natural products on a same platform under exactly the same experimental conditions have not been conducted. In addition, whether administration of these natural antioxidants could increase the efflux of cadmium out of the body remains to be investigated.

8. Other Potential Interventional Approaches

In addition to the plant extracts, herbs and pharmacological agents as shown in Table 1, there are other approaches that have also been applied to counteract cadmium-induced kidney injury. For example, caloric restriction as an established interventional approach for aging and age-related diseases [187,188,189,190] has been demonstrated to mitigate cadmium-induced renal toxicity and kidney dysfunction [191]. Dietary restriction of calcium intake has also been shown to enhance cadmium-induced expression of metallothionein, which could minimize cadmium toxicity [192]. The protective effects of preconditioning and postconditioning observed in numerous studies [193,194,195], if any, elicited by a variety of approaches including ischemia, hypoxia, chemicals or pharmacological agents are yet to be investigated. Additionally, metal chelation using specific chelating agents may also be considered as an interventional approach [196]. Recent findings that persulfide and polysulfide can bind to cadmium thereby decreasing cadmium toxicity [197,198,199] may also provide potential approaches for counteracting cadmium-induced kidney injury.

9. Postulated Model of Cadmium-Induced Proximal Tubule Lesion

Prozialeck and Edwards proposed a model of proximal convoluted tubular cell injury in 2012 [50] that we think elaborates very well the mechanism of cadmium-induced kidney injury in terms of oxidative damage as a unifying mechanism. This model is similar to what has been proposed to explain the mechanisms of ischemic acute kidney injury [8,10,200,201]. Essentially, as diagramed in Figure 6, under healthy conditions and in the absence of cadmium deposit and accumulation, epithelial cells in the proximal tubule are closely associated with each other via specialized junctional structures. These epithelial cells align orderly and tightly on the tubular basement membrane via local adhesion molecules to collectively achieve filtration and reabsorption. In the presence of cadmium, which can accumulate in the cytosolic and mitochondrial compartments, cadmium binds thiol-containing proteins and peptides, leading to functional impairment of these cadmium-bound proteins and peptides. Consequently, such impairments cause mitochondrial electron leakage or NADPH oxidase dysfunction, resulting in enhanced production of ROS and elevated levels of oxidative stress. If the oxidative stress is mild, the tubular cells can repair themselves and resume normal function. It should be noted that this self-repair is likely achieved by de-differentiated tubular epithelial cells instead of differentiated and fixed tubular progenitor cells [202,203]. However, if the oxidative stress is severe and overwhelms cellular repair capacity, an irreversible damage process occurs and cells die by means of apoptosis, necrosis or both [204,205], leading to cell-cell and cell-basement membrane dissociations. This would lead to proteinuria, polyuria, and a progressive decline in kidney function. This functional decline, however, may be intervened and halted by the antioxidative approaches shown in Table 1 if applied appropriately. It should be pointed out that in order to distinguish cadmium-induced proteinuria from primary glomerular lesion, the magnitude of proteinuria and a cadmium concentration dependent manner will need to be characterized.

10. Diagnosis of Cadmium-Induced Kidney Injury

While diagnosis of cadmium-induced kidney injury is complicated by factors such as dosage of exposure, duration of exposure, early stage injury or late stage irreversible injury as well as whether there does any exist underlying disease, a series of parameters could be combined to indicate whether a kidney injury is caused by cadmium exposure. These parameters include measurements of blood and urine cadmium, urinary metallothionein, urinary β2-microglobulin and N-acetyl-β-glucosaminidase. In addition, kidney injury molecule-1 (Kim-1) could also be used to indicate early stage of cadmium-induced proximal tubular injury [50]. Moreover, severe cadmium poisoning could also cause pains in the spine and joints [24]. Collectively, measurements of these biomarkers or indices should provide good evidence that a cadmium-caused kidney injury has occurred. It should be noted that once these biomarkers appear and are detectable, cadmium induced kidney injury might be at an advanced stage that is irreversible. Therefore, novel biomarkers of cadmium-induced early stage kidney injury remain to be explored.

11. Summary

Cadmium exposure and cadmium-induced kidney disease are major public health issues. Mitochondria and NADPH oxidase can be impaired by cadmium that accumulates in the proximal tubular site of nephrons, and thus, are the major sources of ROS. Therefore, the main underlying mechanism of cadmium renal toxicity is enhanced oxidative stress and associated damage to DNA, proteins, and lipids, eventually leading to cell death, kidney injury, and decline in kidney function (Figure 5). Given that cadmium exposure is inevitable in the foreseeable future, cadmium-induced animal models of kidney disease should continue to play an important role in investigating the etiological, pathological, pharmacogenetic, pharmacological, and therapeutic aspects of cadmium-induced kidney disorders. Finally, in addition to elucidating the detailed mechanisms of cadmium-caused mitochondrial oxidative stress and redox imbalance, future studies should also explore novel biomarkers that can be used to diagnose early kidney injury by cadmium exposure. Moreover, whether administration of natural products such as those listed in Table 1 could increase the efflux of cadmium out of the body remains to be investigated.

Author Contributions

Conceptulization, L.-J.Y.; original draft preparation, L.-J.Y.; review and editing, D.C.A. and L.-J.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Koeppen, B.M.; Stanton, B.A. Renal Physiology, 5th ed.; Elsevier: Philadelphia, PA, USA, 2013. [Google Scholar]
  2. Rennke, H.G.; Denker, B.M. Renal Pathology: The Essentials, 5th ed.; Wolters Kluwer: New York, NY, USA, 2020. [Google Scholar]
  3. Dipiro, J.T.; Talbet, R.L.; Yee, G.C.; Matzke, G.R.; Wells, B.G.; Posey, L.M. Pharmacotherapy: A Pathophysiological Approach, 9th ed.; McGraw-Hill Education: New York, NY, USA, 2014. [Google Scholar]
  4. Sumida, K.D.; Garrett, J.H.; McJilton, W.T.; Hevener, A.L.; Donovan, C.M. Effect of endurance training and fasting on renal gluconeogenic enzymes in the rat. Int. J. Sport Nutr. Exerc. Metab. 2004, 14, 323–332. [Google Scholar] [CrossRef]
  5. Kaneko, K.; Soty, M.; Zitoun, C.; Duchampt, A.; Silva, M.; Philippe, E.; Gautier-Stein, A.; Rajas, F.; Mithieux, G. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting. Mol. Metab. 2018, 16, 203–212. [Google Scholar] [CrossRef]
  6. Sharma, R.; Tiwari, S. Renal gluconeogenesis in insulin resistance: A culprit for hyperglycemia in diabetes. World J. Diabetes 2021, 12, 556–568. [Google Scholar] [CrossRef] [PubMed]
  7. Lieberman, M.; Marks, A.D. Marks’ Basic Medical Biochemistry: A Clinical Approach, 4th ed.; Wolters Kluwer/Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2013. [Google Scholar]
  8. Molitoris, B.A.; Marrs, J. The role of cell adhesion molecules in ischemic acute renal failure. Am. J. Med. 1999, 106, 583–592. [Google Scholar] [CrossRef]
  9. Scholz, H.; Boivin, F.J.; Schmidt-Ott, K.M.; Bachmann, S.; Eckardt, K.U.; Scholl, U.I.; Persson, P.B. Kidney physiology and susceptibility to acute kidney injury: Implications for renoprotection. Nat. Rev. Nephrol. 2021, 17, 335–349. [Google Scholar] [CrossRef]
  10. Zhuang, S.; Lu, B.; Daubert, R.A.; Chavin, K.D.; Wang, L.; Schnellmann, R.G. Suramin promotes recovery from renal ischemia/reperfusion injury in mice. Kidney Int. 2009, 75, 304–311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Tran, M.; Tam, D.; Bardia, A.; Bhasin, M.; Rowe, G.C.; Kher, A.; Zsengeller, Z.K.; Akhavan-Sharif, M.R.; Khankin, E.V.; Saintgeniez, M.; et al. Pgc-1alpha promotes recovery after acute kidney injury during systemic inflammation in mice. J. Clin. Investig. 2011, 121, 4003–4014. [Google Scholar] [CrossRef] [Green Version]
  12. Dare, A.J.; Bolton, E.A.; Pettigrew, G.J.; Bradley, J.A.; Saeb-Parsy, K.; Murphy, M.P. Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant mitoq. Redox Biol. 2015, 5, 163–168. [Google Scholar] [CrossRef] [Green Version]
  13. Perazella, M.A. Renal vulnerability to drug toxicity. Clin. J. Am. Soc. Nephrol. 2009, 4, 1275–1283. [Google Scholar] [CrossRef]
  14. Cohen, A.; Ioannidis, K.; Ehrlich, A.; Regenbaum, S.; Cohen, M.; Ayyash, M.; Tikva, S.S.; Nahmias, Y. Mechanism and reversal of drug-induced nephrotoxicity on a chip. Sci. Transl. Med. 2021, 13, eabd6299. [Google Scholar] [CrossRef]
  15. Hosohata, K. Role of oxidative stress in drug-induced kidney injury. Int. J. Mol. Sci. 2016, 17, 1826. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Osman, A.T.; Sharkawi, S.M.Z.; Hassan, M.I.A.; Abo-Youssef, A.M.; Hemeida, R.A.M. Empagli fl ozin and neohesperidin protect against methotrexate-induced renal toxicity via suppression of oxidative stress and inflammation in male rats. Food Chem. Toxicol. 2021, 155, 112406. [Google Scholar] [CrossRef] [PubMed]
  17. Haider, L.; Sharif, S.; Hasan, A.; McFarlane, I.M. Low-dose methotrexate toxicity in the setting of vancomycin-induced acute kidney injury. Am. J. Med. Case Rep. 2020, 8, 206–209. [Google Scholar] [CrossRef] [PubMed]
  18. Hall, A.M.; Trepiccione, F.; Unwin, R.J. Drug toxicity in the proximal tubule: New models, methods and mechanisms. Pediatr. Nephrol. 2021. [Google Scholar] [CrossRef] [PubMed]
  19. Wen, J.; Zeng, M.; Shu, Y.; Guo, D.; Sun, Y.; Guo, Z.; Wang, Y.; Liu, Z.; Zhou, H.; Zhang, W. Aging increases the susceptibility of cisplatin-induced nephrotoxicity. Age 2015, 37, 112. [Google Scholar] [CrossRef] [Green Version]
  20. Lash, L.H. Diverse roles of mitochondria in renal injury from environmental toxicants and therapeutic drugs. Int. J. Mol. Sci. 2021, 22, 4172. [Google Scholar] [CrossRef]
  21. Bharavi, K.; Reddy, A.G.; Rao, G.S.; Reddy, A.R.; Rao, S.V. Reversal of cadmium-induced oxidative stress in chicken by herbal adaptogens withania somnifera and ocimum sanctum. Toxicol. Int. 2010, 17, 59–63. [Google Scholar] [CrossRef] [Green Version]
  22. Kataria, A.; Trasande, L.; Trachtman, H. The effects of environmental chemicals on renal function. Nat. Rev. Nephrol. 2015, 11, 610–625. [Google Scholar] [CrossRef]
  23. Johri, N.; Jacquillet, G.; Unwin, R. Heavy metal poisoning: The effects of cadmium on the kidney. Biometals 2010, 23, 783–792. [Google Scholar] [CrossRef]
  24. Vervaet, B.A.; D’Haese, P.C.; Verhulst, A. Environmental toxin-induced acute kidney injury. Clin. Kidney J. 2017, 10, 747–758. [Google Scholar] [CrossRef] [Green Version]
  25. Rizwan, S.; Naqshbandi, A.; Farooqui, Z.; Khan, A.A.; Khan, F. Protective effect of dietary flaxseed oil on arsenic-induced nephrotoxicity and oxidative damage in rat kidney. Food Chem. Toxicol. 2014, 68, 99–107. [Google Scholar] [CrossRef]
  26. Kimura, A.; Ishida, Y.; Hayashi, T.; Wada, T.; Yokoyama, H.; Sugaya, T.; Mukaida, N.; Kondo, T. Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am. J. Pathol. 2006, 169, 1118–1128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Barregard, L.; Bergstrom, G.; Fagerberg, B. Cadmium, type 2 diabetes, and kidney damage in a cohort of middle-aged women. Environ. Res. 2014, 135, 311–316. [Google Scholar] [CrossRef] [PubMed]
  28. Gangadhariah, M.H.; Luther, J.M.; Garcia, V.; Paueksakon, P.; Zhang, M.Z.; Hayward, S.W.; Love, H.D.; Falck, J.R.; Manthati, V.L.; Imig, J.D.; et al. Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy. J. Am. Soc. Nephrol. 2015, 26, 597–610. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Wang, Z.; do Carmo, J.M.; da Silva, A.A.; Fu, Y.; Hall, J.E. Mechanisms of synergistic interactions of diabetes and hypertension in chronic kidney disease: Role of mitochondrial dysfunction and er stress. Curr. Hypertens Rep. 2020, 22, 15. [Google Scholar] [CrossRef] [PubMed]
  30. Ware, K.; Yildiz, V.; Xiao, M.; Medipally, A.; Hemminger, J.; Scarl, R.; Satoskar, A.A.; Hebert, L.; Ivanov, I.; Biederman, L.; et al. Hypertension and the kidney: Reduced kidney mass is bad for both normotensive and hypertensive rats. Am. J. Hypertens 2021. [Google Scholar] [CrossRef] [PubMed]
  31. Narsipur, S.S.; Peterson, O.W.; Smith, R.; Bigby, T.D.; Parthasarathy, S.; Gabbai, F.B.; Wilson, C.B.; Blantz, R.C. Mechanisms of glomerular immune injury: Effects of antioxidant treatment. J. Am. Soc. Nephrol. 2003, 14, 1748–1755. [Google Scholar] [CrossRef] [Green Version]
  32. Duann, P.; Lianos, E.A. Mechanisms of ho-1 mediated attenuation of renal immune injury: A gene profiling study. Transl. Res. 2011, 158, 249–261. [Google Scholar] [CrossRef]
  33. Persson, F.; Rossing, P. Diagnosis of diabetic kidney disease: State of the art and future perspective. Kidney Int. Suppl. 2018, 8, 2–7. [Google Scholar] [CrossRef] [Green Version]
  34. Hallan, S.; Sharma, K. The role of mitochondria in diabetic kidney disease. Curr. Diabetes Rep. 2016, 16, 61. [Google Scholar] [CrossRef] [PubMed]
  35. Wei, P.Z.; Szeto, C.C. Mitochondrial dysfunction in diabetic kidney disease. Clin. Chim. Acta 2019, 496, 108–116. [Google Scholar] [CrossRef]
  36. Yan, L.J. Nadh/nad(+) redox imbalance and diabetic kidney disease. Biomolecules 2021, 11, 730. [Google Scholar] [CrossRef]
  37. Orr, S.E.; Bridges, C.C. Chronic kidney disease and exposure to nephrotoxic metals. Int. J. Mol. Sci. 2017, 18, 1039. [Google Scholar] [CrossRef] [Green Version]
  38. Edwards, J.R.; Prozialeck, W.C. Cadmium, diabetes and chronic kidney disease. Toxicol. Appl. Pharmacol. 2009, 238, 289–293. [Google Scholar] [CrossRef] [Green Version]
  39. Almeer, R.S.; AlBasher, G.I.; Alarifi, S.; Alkahtani, S.; Ali, D.; Abdel Moneim, A.E. Royal jelly attenuates cadmium-induced nephrotoxicity in male mice. Sci. Rep. 2019, 9, 5825. [Google Scholar] [CrossRef] [Green Version]
  40. Almeer, R.S.; Kassab, R.B.; AlBasher, G.I.; Alarifi, S.; Alkahtani, S.; Ali, D.; Abdel Moneim, A.E. Royal jelly mitigates cadmium-induced neuronal damage in mouse cortex. Mol. Biol. Rep. 2019, 46, 119–131. [Google Scholar] [CrossRef] [PubMed]
  41. Aurisano, N.; Huang, L.; Mila, I.C.L.; Jolliet, O.; Fantke, P. Chemicals of concern in plastic toys. Environ. Int. 2021, 146, 106194. [Google Scholar] [CrossRef] [PubMed]
  42. Chen, C.; Han, X.; Wang, G.; Liu, D.; Bao, L.; Jiao, C.; Luan, J.; Hou, Y.; Xu, Y.; Wang, H.; et al. Nrf2 deficiency aggravates the kidney injury induced by subacute cadmium exposure in mice. Arch. Toxicol. 2021, 95, 883–893. [Google Scholar] [CrossRef] [PubMed]
  43. Satarug, S.; Nishijo, M.; Lasker, J.M.; Edwards, R.J.; Moore, M.R. Kidney dysfunction and hypertension: Role for cadmium, p450 and heme oxygenases? Tohoku J. Exp. Med. 2006, 208, 179–202. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Hao, R.; Song, X.; Sun-Waterhouse, D.; Tan, X.; Li, F.; Li, D. Mir-34a/sirt1/p53 signaling pathway contributes to cadmium-induced nephrotoxicity: A preclinical study in mice. Environ. Pollut 2021, 282, 117029. [Google Scholar] [CrossRef]
  45. Kim, K.S.; Lim, H.J.; Lim, J.S.; Son, J.Y.; Lee, J.; Lee, B.M.; Chang, S.C.; Kim, H.S. Curcumin ameliorates cadmium-induced nephrotoxicity in sprague-dawley rats. Food Chem. Toxicol. 2018, 114, 34–40. [Google Scholar] [CrossRef]
  46. Tripathi, S.; Srivastav, A.K. Cytoarchitectural alterations in kidney of wistar rat after oral exposure to cadmium chloride. Tissue Cell 2011, 43, 131–136. [Google Scholar] [CrossRef]
  47. Rikans, L.E.; Yamano, T. Mechanisms of cadmium-mediated acute hepatotoxicity. J. Biochem. Mol. Toxicol. 2000, 14, 110–117. [Google Scholar] [CrossRef]
  48. Kim, S.C.; Cho, M.K.; Kim, S.G. Cadmium-induced non-apoptotic cell death mediated by oxidative stress under the condition of sulfhydryl deficiency. Toxicol. Lett. 2003, 144, 325–336. [Google Scholar] [CrossRef]
  49. Godt, J.; Scheidig, F.; Grosse-Siestrup, C.; Esche, V.; Brandenburg, P.; Reich, A.; Groneberg, D.A. The toxicity of cadmium and resulting hazards for human health. J. Occup. Med. Toxicol. 2006, 1, 22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Prozialeck, W.C.; Edwards, J.R. Mechanisms of cadmium-induced proximal tubule injury: New insights with implications for biomonitoring and therapeutic interventions. J. Pharmacol. Exp. Ther. 2012, 343, 2–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Prozialeck, W.C.; Vaidya, V.S.; Liu, J.; Waalkes, M.P.; Edwards, J.R.; Lamar, P.C.; Bernard, A.M.; Dumont, X.; Bonventre, J.V. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int. 2007, 72, 985–993. [Google Scholar] [CrossRef] [Green Version]
  52. Shaikh, Z.A.; Lucis, O.J. Cadmium and zinc binding in mammalian liver and kidneys. Arch. Environ. Health 1972, 24, 419–425. [Google Scholar] [CrossRef]
  53. Shaikh, Z.A.; Lucis, O.J. Biological differences in cadmium and zinc turnover. Arch. Environ. Health 1972, 24, 410–418. [Google Scholar] [CrossRef]
  54. Liu, J.; Liu, Y.; Habeebu, S.S.; Klaassen, C.D. Susceptibility of mt-null mice to chronic cdcl2-induced nephrotoxicity indicates that renal injury is not mediated by the cdmt complex. Toxicol. Sci. 1998, 46, 197–203. [Google Scholar]
  55. Klaassen, C.D.; Liu, J. Role of metallothionein in cadmium-induced hepatotoxicity and nephrotoxicity. Drug Metab. Rev. 1997, 29, 79–102. [Google Scholar] [CrossRef]
  56. Nomiyama, K.; Nomiyama, H. Tissue metallothioneins in rabbits chronically exposed to cadmium, with special reference to the critical concentration of cadmium in the renal cortex. Dev. Toxicol. Environ. Sci. 1982, 9, 47–67. [Google Scholar] [PubMed]
  57. Nomiyama, K.; Nomiyama, H. Critical concentration of ‘unbound’ cadmium in the rabbit renal cortex. Experientia 1986, 42, 149. [Google Scholar] [CrossRef] [PubMed]
  58. Prozialeck, W.C.; Edwards, J.R.; Lamar, P.C.; Liu, J.; Vaidya, V.S.; Bonventre, J.V. Expression of kidney injury molecule-1 (kim-1) in relation to necrosis and apoptosis during the early stages of cd-induced proximal tubule injury. Toxicol. Appl. Pharmacol. 2009, 238, 306–314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Fels, J.; Scharner, B.; Zarbock, R.; Zavala Guevara, I.P.; Lee, W.K.; Barbier, O.C.; Thevenod, F. Cadmium complexed with beta2-microglubulin, albumin and lipocalin-2 rather than metallothionein cause megalin:Cubilin dependent toxicity of the renal proximal tubule. Int. J. Mol. Sci. 2019, 20, 2379. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Nair, A.R.; Lee, W.K.; Smeets, K.; Swennen, Q.; Sanchez, A.; Thevenod, F.; Cuypers, A. Glutathione and mitochondria determine acute defense responses and adaptive processes in cadmium-induced oxidative stress and toxicity of the kidney. Arch. Toxicol. 2015, 89, 2273–2289. [Google Scholar] [CrossRef]
  61. Bagchi, D.; Bagchi, M.; Hassoun, E.A.; Stohs, S.J. Cadmium-induced excretion of urinary lipid metabolites, DNA damage, glutathione depletion, and hepatic lipid peroxidation in sprague-dawley rats. Biol. Trace Elem. Res. 1996, 52, 143–154. [Google Scholar] [CrossRef]
  62. Hassoun, E.A.; Stohs, S.J. Cadmium-induced production of superoxide anion and nitric oxide, DNA single strand breaks and lactate dehydrogenase leakage in j774a.1 cell cultures. Toxicology 1996, 112, 219–226. [Google Scholar] [CrossRef]
  63. Sotomayor, C.G.; Groothof, D.; Vodegel, J.J.; Eisenga, M.F.; Knobbe, T.J.; IJmker, J.; Lammerts, R.G.M.; de Borst, M.H.; Berger, S.P.; Nolte, I.M.; et al. Plasma cadmium is associated with increased risk of long-term kidney graft failure. Kidney Int. 2021, 99, 1213–1224. [Google Scholar] [CrossRef]
  64. Fransson, M.N.; Barregard, L.; Sallsten, G.; Akerstrom, M.; Johanson, G. Physiologically-based toxicokinetic model for cadmium using markov-chain monte carlo analysis of concentrations in blood, urine, and kidney cortex from living kidney donors. Toxicol. Sci. 2014, 141, 365–376. [Google Scholar] [CrossRef] [Green Version]
  65. Jarup, L. Cadmium overload and toxicity. Nephrol. Dial. Transplant. 2002, 17, 35–39. [Google Scholar] [CrossRef] [Green Version]
  66. Jarup, L.; Persson, B.; Elinder, C.G. Decreased glomerular filtration rate in solderers exposed to cadmium. Occup. Environ. Med. 1995, 52, 818–822. [Google Scholar] [CrossRef] [Green Version]
  67. Kazantzis, G. Renal tubular dysfunction and abnormalities of calcium metabolism in cadmium workers. Environ. Health Perspect. 1979, 28, 155–159. [Google Scholar] [CrossRef]
  68. Chen, S.; Liu, G.; Long, M.; Zou, H.; Cui, H. Alpha lipoic acid attenuates cadmium-induced nephrotoxicity via the mitochondrial apoptotic pathways in rat. J. Inorg. Biochem. 2018, 184, 19–26. [Google Scholar] [CrossRef]
  69. Prozialeck, W.C.; Edwards, J.R.; Vaidya, V.S.; Bonventre, J.V. Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity. Toxicol. Appl. Pharmacol. 2009, 238, 301–305. [Google Scholar] [CrossRef] [Green Version]
  70. Sarma, S.N.; Saleem, A.; Lee, J.Y.; Tokumoto, M.; Hwang, G.W.; Man Chan, H.; Satoh, M. Effects of long-term cadmium exposure on urinary metabolite profiles in mice. J. Toxicol. Sci. 2018, 43, 89–100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Porter, G.A. Risk factors for toxic nephropathies. Toxicol. Lett. 1989, 46, 269–279. [Google Scholar] [CrossRef]
  72. Nath, R.; Prasad, R.; Palinal, V.K.; Chopra, R.K. Molecular basis of cadmium toxicity. Prog. Food Nutr. Sci. 1984, 8, 109–163. [Google Scholar]
  73. Gong, P.; Wang, M.; Yang, W.; Chang, X.; Wang, L.; Chen, F. Integrated metabolomics coupled with pattern recognition and pathway analysis to reveal molecular mechanism of cadmium-induced diabetic nephropathy. Toxicol. Res. 2021, 10, 777–791. [Google Scholar] [CrossRef]
  74. Gong, P.; Chang, X.; Chen, X.; Bai, X.; Wen, H.; Pi, S.; Yang, W.; Wang, L.; Chen, F. Metabolomics study of cadmium-induced diabetic nephropathy and protective effect of caffeic acid phenethyl ester using uplc-q-tof-ms combined with pattern recognition. Environ. Toxicol. Pharmacol. 2017, 54, 80–92. [Google Scholar] [CrossRef] [PubMed]
  75. Zhou, B.; Gentry, A.; Xu, Q.; Young, J.L.; Yan, X.; Pagidas, K.; Yang, Y.; Watson, W.H.; Kong, M.; Cai, L.; et al. Effects of cadmium and high-fat diet on essential metal concentration in the mouse testis. Toxicol. Rep. 2021, 8, 718–723. [Google Scholar] [CrossRef] [PubMed]
  76. Hagedoorn, I.J.M.; Gant, C.M.; Huizen, S.V.; Maatman, R.; Navis, G.; Bakker, S.J.L.; Laverman, G.D. Lifestyle-related exposure to cadmium and lead is associated with diabetic kidney disease. J. Clin. Med. 2020, 9, 2432. [Google Scholar] [CrossRef] [PubMed]
  77. Shah, S.; Iqbal, M.; Karam, J.; Salifu, M.; McFarlane, S.I. Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: Pathophysiological insights. Antioxid. Redox Signal. 2007, 9, 911–929. [Google Scholar] [CrossRef] [PubMed]
  78. Sanjeev, S.; Bidanchi, R.M.; Murthy, M.K.; Gurusubramanian, G.; Roy, V.K. Influence of ferulic acid consumption in ameliorating the cadmium-induced liver and renal oxidative damage in rats. Environ. Sci Pollut Res. Int. 2019, 26, 20631–20653. [Google Scholar] [CrossRef] [PubMed]
  79. Zhang, H.; Reynolds, M. Cadmium exposure in living organisms: A short review. Sci. Total Environ. 2019, 678, 761–767. [Google Scholar] [CrossRef]
  80. Cannino, G.; Ferruggia, E.; Luparello, C.; Rinaldi, A.M. Cadmium and mitochondria. Mitochondrion 2009, 9, 377–384. [Google Scholar] [CrossRef]
  81. Genchi, G.; Sinicropi, M.S.; Lauria, G.; Carocci, A.; Catalano, A. The effects of cadmium toxicity. Int. J. Environ. Res. Public Health 2020, 17, 3782. [Google Scholar] [CrossRef] [PubMed]
  82. Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417, 1–13. [Google Scholar] [CrossRef] [Green Version]
  83. Rosca, M.G.; Vazquez, E.J.; Chen, Q.; Kerner, J.; Kern, T.S.; Hoppel, C.L. Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes 2012, 61, 2074–2083. [Google Scholar] [CrossRef] [Green Version]
  84. Sena, L.A.; Chandel, N.S. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 2012, 48, 158–167. [Google Scholar] [CrossRef] [Green Version]
  85. Bhargava, P.; Schnellmann, R.G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 2017, 13, 629–646. [Google Scholar] [CrossRef] [PubMed]
  86. Trewin, A.J.; Bahr, L.L.; Almast, A.; Berry, B.J.; Wei, A.Y.; Foster, T.H.; Wojtovich, A.P. Mitochondrial reactive oxygen species generated at the complex-ii matrix or intermembrane space microdomain have distinct effects on redox signaling and stress sensitivity in caenorhabditis elegans. Antioxid. Redox Signal. 2019, 31, 594–607. [Google Scholar] [CrossRef]
  87. Ralph, S.J.; Moreno-Sanchez, R.; Neuzil, J.; Rodriguez-Enriquez, S. Inhibitors of succinate: Quinone reductase/complex ii regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death. Pharm. Res. 2011, 28, 2695–2730. [Google Scholar] [CrossRef] [PubMed]
  88. Brand, M.D. Riding the tiger—Physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix. Crit. Rev. Biochem. Mol. Biol. 2020, 55, 592–661. [Google Scholar] [CrossRef]
  89. Brand, M.D.; Goncalves, R.L.; Orr, A.L.; Vargas, L.; Gerencser, A.A.; Borch Jensen, M.; Wang, Y.T.; Melov, S.; Turk, C.N.; Matzen, J.T.; et al. Suppressors of superoxide-h2o2 production at site iq of mitochondrial complex i protect against stem cell hyperplasia and ischemia-reperfusion injury. Cell Metab. 2016, 24, 582–592. [Google Scholar] [CrossRef] [Green Version]
  90. Ames, B.N.; Shigenaga, M.K. Oxidants are a major contributor to aging. Ann. N. Y. Acad. Sci. 1992, 663, 85–96. [Google Scholar] [CrossRef]
  91. Yan, L.J. Pathogenesis of chronic hyperglycemia: From reductive stress to oxidative stress. J. Diabetes Res. 2014, 2014, 137919. [Google Scholar] [CrossRef] [Green Version]
  92. Salvemini, D.; Doyle, T.M.; Cuzzocrea, S. Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation. Biochem. Soc. Trans. 2006, 34, 965–970. [Google Scholar] [CrossRef]
  93. Kassab, A.; Piwowar, A. Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes. Biochimie 2012, 94, 1837–1848. [Google Scholar] [CrossRef] [PubMed]
  94. Klivenyi, P.; Starkov, A.A.; Calingasan, N.Y.; Gardian, G.; Browne, S.E.; Yang, L.; Bubber, P.; Gibson, G.E.; Patel, M.S.; Beal, M.F. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to mptp, malonate and 3-nitropropionic acid neurotoxicity. J. Neurochem. 2004, 88, 1352–1360. [Google Scholar] [CrossRef] [PubMed]
  95. Vaubel, R.A.; Rustin, P.; Isaya, G. Mutations in the dimer interface of dihydrolipoamide dehydrogenase promote site-specific oxidative damages in yeast and human cells. J. Biol. Chem. 2011, 286, 40232–40245. [Google Scholar] [CrossRef] [Green Version]
  96. Ambrus, A.; Torocsik, B.; Tretter, L.; Ozohanics, O.; Adam-Vizi, V. Stimulation of reactive oxygen species generation by disease-causing mutations of lipoamide dehydrogenase. Hum. Mol. Genet. 2011, 20, 2984–2995. [Google Scholar] [CrossRef] [Green Version]
  97. Bunik, V.I.; Brand, M.D. Generation of superoxide and hydrogen peroxide by side reactions of mitochondrial 2-oxoacid dehydrogenase complexes in isolation and in cells. Biol. Chem. 2018, 399, 407–420. [Google Scholar] [CrossRef]
  98. Wang, Y.; Fang, J.; Leonard, S.S.; Rao, K.M. Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic. Biol. Med. 2004, 36, 1434–1443. [Google Scholar] [CrossRef]
  99. Sedeek, M.; Nasrallah, R.; Touyz, R.M.; Hebert, R.L. Nadph oxidases, reactive oxygen species, and the kidney: Friend and foe. J. Am. Soc. Nephrol. 2013, 24, 1512–1518. [Google Scholar] [CrossRef]
  100. Suh, Y.A.; Arnold, R.S.; Lassegue, B.; Shi, J.; Xu, X.; Sorescu, D.; Chung, A.B.; Griendling, K.K.; Lambeth, J.D. Cell transformation by the superoxide-generating oxidase mox1. Nature 1999, 401, 79–82. [Google Scholar] [CrossRef] [PubMed]
  101. Cheng, G.; Cao, Z.; Xu, X.; van Meir, E.G.; Lambeth, J.D. Homologs of gp91phox: Cloning and tissue expression of nox3, nox4, and nox5. Gene 2001, 269, 131–140. [Google Scholar] [CrossRef]
  102. Gardiner, G.J.; Deffit, S.N.; McLetchie, S.; Perez, L.; Walline, C.C.; Blum, J.S. A role for nadph oxidase in antigen presentation. Front. Immunol 2013, 4, 295. [Google Scholar] [CrossRef] [Green Version]
  103. Drummond, G.R.; Selemidis, S.; Griendling, K.K.; Sobey, C.G. Combating oxidative stress in vascular disease: Nadph oxidases as therapeutic targets. Nat. Rev. Drug Discov. 2011, 10, 453–471. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Cho, S.; Yu, S.L.; Kang, J.; Jeong, B.Y.; Lee, H.Y.; Park, C.G.; Yu, Y.B.; Jin, D.C.; Hwang, W.M.; Yun, S.R.; et al. Nadph oxidase 4 mediates tgf-beta1/smad signaling pathway induced acute kidney injury in hypoxia. PLoS ONE 2019, 14, e0219483. [Google Scholar]
  105. Liu, Q.; Liang, X.; Liang, M.; Qin, R.; Qin, F.; Wang, X. Ellagic acid ameliorates renal ischemic-reperfusion injury through nox4/jak/stat signaling pathway. Inflammation 2020, 43, 298–309. [Google Scholar] [CrossRef]
  106. Lima, N.K.S.; Farias, W.R.A.; Cirilo, M.A.S.; Oliveira, A.G.; Farias, J.S.; Aires, R.S.; Muzi-Filho, H.; Paixao, A.D.O.; Vieira, L.D. Renal ischemia-reperfusion leads to hypertension and changes in proximal tubule na(+) transport and renin-angiotensin-aldosterone system: Role of nadph oxidase. Life Sci. 2021, 266, 118879. [Google Scholar] [CrossRef]
  107. Pinheiro Junior, J.E.G.; Moraes, P.Z.; Rodriguez, M.D.; Simoes, M.R.; Cibin, F.; Pinton, S.; Barbosa Junior, F.; Pecanha, F.M.; Vassallo, D.V.; Miguel, M.; et al. Cadmium exposure activates nadph oxidase, renin-angiotensin system and cyclooxygenase 2 pathways in arteries, inducing hypertension and vascular damage. Toxicol. Lett. 2020, 333, 80–89. [Google Scholar] [CrossRef]
  108. Asagba, S.O. Alteration in the activity of oxidative enzymes in the tissues of male wistar albino rats exposed to cadmium. Int. J. Occup. Med. Environ. Health 2010, 23, 55–62. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  109. Greene, E.L.; Paller, M.S. Xanthine oxidase produces o2-. In posthypoxic injury of renal epithelial cells. Am. J. Physiol. 1992, 263, F251–F255. [Google Scholar] [CrossRef] [PubMed]
  110. Ratliff, B.B.; Abdulmahdi, W.; Pawar, R.; Wolin, M.S. Oxidant mechanisms in renal injury and disease. Antioxid. Redox Signal. 2016, 25, 119–146. [Google Scholar] [CrossRef] [Green Version]
  111. Noris, M.; Remuzzi, G. Physiology and pathophysiology of nitric oxide in chronic renal disease. Proc. Assoc. Am. Physicians 1999, 111, 602–610. [Google Scholar] [CrossRef]
  112. Soyupek, S.; Oksay, T.; Sutcu, R.; Armagan, A.; Gokalp, O.; Perk, H.; Delibas, N. The effect of cadmium toxicity on renal nitric oxide synthase isoenzymes. Toxicol. Ind. Health 2012, 28, 624–628. [Google Scholar] [CrossRef] [PubMed]
  113. Pavon, N.; Buelna-Chontal, M.; Macias-Lopez, A.; Correa, F.; Uribe-Alvarez, C.; Hernandez-Esquivel, L.; Chavez, E. On the oxidative damage by cadmium to kidney mitochondrial functions. Biochem. Cell Biol. 2019, 97, 187–192. [Google Scholar] [CrossRef]
  114. Thevenod, F.; Lee, W.K.; Garrick, M.D. Iron and cadmium entry into renal mitochondria: Physiological and toxicological implications. Front. Cell Dev. Biol 2020, 8, 848. [Google Scholar] [CrossRef]
  115. Liu, Q.; Zhang, R.; Wang, X.; Shen, X.; Wang, P.; Sun, N.; Li, X.; Li, X.; Hai, C. Effects of sub-chronic, low-dose cadmium exposure on kidney damage and potential mechanisms. Ann. Transl. Med. 2019, 7, 177. [Google Scholar] [CrossRef]
  116. Ghasemi, H.; Postampour, F.; Ranjbar, A. The role of oxidative stress in metals toxicity/mitochondrial dysfunction as a key player. GMJ 2014, 3, 2–13. [Google Scholar]
  117. Barnett, L.M.A.; Cummings, B.S. Nephrotoxicity and renal pathophysiology: A contemporary perspective. Toxicol. Sci. 2018, 164, 379–390. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  118. Gobe, G.; Crane, D. Mitochondria, reactive oxygen species and cadmium toxicity in the kidney. Toxicol. Lett. 2010, 198, 49–55. [Google Scholar] [CrossRef]
  119. Ge, J.; Zhang, C.; Sun, Y.C.; Zhang, Q.; Lv, M.W.; Guo, K.; Li, J.L. Cadmium exposure triggers mitochondrial dysfunction and oxidative stress in chicken (Gallus gallus) kidney via mitochondrial upr inhibition and nrf2-mediated antioxidant defense activation. Sci. Total Environ. 2019, 689, 1160–1171. [Google Scholar] [CrossRef] [PubMed]
  120. Sandbichler, A.M.; Hockner, M. Cadmium protection strategies—A hidden trade-off? Int. J. Mol. Sci 2016, 17, 139. [Google Scholar] [CrossRef] [Green Version]
  121. Li, X.; Zhang, H.; Sun, F. Cdse/zns quantum dots exhibited nephrotoxicity through mediating oxidative damage and inflammatory response. Aging 2020, 13, 12194–12206. [Google Scholar] [CrossRef]
  122. Wang, X.Y.; Wang, Z.Y.; Zhu, Y.S.; Zhu, S.M.; Fan, R.F.; Wang, L. Alleviation of cadmium-induced oxidative stress by trehalose via inhibiting the nrf2-keap1 signaling pathway in primary rat proximal tubular cells. J. Biochem. Mol. Toxicol. 2018, 32, e22011. [Google Scholar] [CrossRef]
  123. Ashrafizadeh, M.; Ahmadi, Z.; Farkhondeh, T.; Samarghandian, S. Back to nucleus: Combating with cadmium toxicity using nrf2 signaling pathway as a promising therapeutic target. Biol. Trace Elem. Res. 2020, 197, 52–62. [Google Scholar] [CrossRef] [PubMed]
  124. Choudhury, C.; Mazumder, R.; Kumar, R.; Dhar, B.; Sengupta, M. Cadmium induced oxystress alters nrf2-keap1 signaling and triggers apoptosis in piscine head kidney macrophages. Aquat. Toxicol. 2021, 231, 105739. [Google Scholar] [CrossRef] [PubMed]
  125. Dastan, D.; Karimi, S.; Larki-Harchegani, A.; Nili-Ahmadabadi, A. Protective effects of allium hirtifolium boiss extract on cadmium-induced renal failure in rats. Environ. Sci. Pollut. Res. Int. 2019, 26, 18886–18892. [Google Scholar] [CrossRef] [PubMed]
  126. Handan, B.A.; De Moura, C.F.G.; Cardoso, C.M.; Santamarina, A.B.; Pisani, L.P.; Ribeiro, D.A. Protective effect of grape and apple juices against cadmium intoxication in the kidney of rats. Drug Res. 2020, 70, 503–511. [Google Scholar] [CrossRef] [PubMed]
  127. Suliman Al-Gebaly, A. Ameliorative effect of arctium lappa against cadmium genotoxicity and histopathology in kidney of wistar rat. Pak. J. Biol. Sci 2017, 20, 314–319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  128. Das, S.; Dewanjee, S.; Dua, T.K.; Joardar, S.; Chakraborty, P.; Bhowmick, S.; Saha, A.; Bhattacharjee, S.; De Feo, V. Carnosic acid attenuates cadmium induced nephrotoxicity by inhibiting oxidative stress, promoting nrf2/ho-1 signalling and impairing tgf-beta1/smad/collagen iv signalling. Molecules 2019, 24, 4176. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  129. Wongmekiat, O.; Peerapanyasut, W.; Kobroob, A. Catechin supplementation prevents kidney damage in rats repeatedly exposed to cadmium through mitochondrial protection. Naunyn. Schmiedebergs Arch. Pharmacol. 2018, 391, 385–394. [Google Scholar] [CrossRef] [PubMed]
  130. Gong, P.; Chen, F.; Liu, X.; Gong, X.; Wang, J.; Ma, Y. Protective effect of caffeic acid phenethyl ester against cadmium-induced renal damage in mice. J. Toxicol. Sci. 2012, 37, 415–425. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  131. Kobroob, A.; Chattipakorn, N.; Wongmekiat, O. Caffeic acid phenethyl ester ameliorates cadmium-induced kidney mitochondrial injury. Chem. Biol. Interact. 2012, 200, 21–27. [Google Scholar] [CrossRef]
  132. Koriem, K.M.; Arbid, M.S.; Asaad, G.F. Chelidonium majus leaves methanol extract and its chelidonine alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats. J. Nat. Med. 2013, 67, 159–167. [Google Scholar] [CrossRef] [PubMed]
  133. Senthilkumar, T.; Sangeetha, N.; Ashokkumar, N. Antihyperglycemic, antihyperlipidemic, and renoprotective effects of chlorella pyrenoidosa in diabetic rats exposed to cadmium. Toxicol. Mech. Methods 2012, 22, 617–624. [Google Scholar] [CrossRef]
  134. Poontawee, W.; Natakankitkul, S.; Wongmekiat, O. Protective effect of Cleistocalyx nervosum var. Paniala fruit extract against oxidative renal damage caused by cadmium. Molecules 2016, 21, 133. [Google Scholar] [CrossRef] [Green Version]
  135. Nishio, R.; Tamano, H.; Morioka, H.; Takeuchi, A.; Takeda, A. Intake of heated leaf extract of coriandrum sativum contributes to resistance to oxidative stress via decreases in heavy metal concentrations in the kidney. Plant. Foods Hum. Nutr 2019, 74, 204–209. [Google Scholar] [CrossRef]
  136. Tubsakul, A.; Sangartit, W.; Pakdeechote, P.; Kukongviriyapan, V.; Apaijit, K.; Kukongviriyapan, U. Curcumin mitigates hypertension, endothelial dysfunction and oxidative stress in rats with chronic exposure to lead and cadmium. Tohoku J. Exp. Med. 2021, 253, 69–76. [Google Scholar] [CrossRef]
  137. Fan, S.R.; Ren, T.T.; Yun, M.Y.; Lan, R.; Qin, X.Y. Edaravone attenuates cadmium-induced toxicity by inhibiting oxidative stress and inflammation in icr mice. Neurotoxicology 2021, 86, 1–9. [Google Scholar] [CrossRef]
  138. Kopec, A.; Sikora, E.; Piatkowska, E.; Borczak, B.; Czech, T. Possible protective role of elderberry fruit lyophilizate against selected effects of cadmium and lead intoxication in wistar rats. Environ. Sci. Pollut Res. Int. 2016, 23, 8837–8848. [Google Scholar] [CrossRef] [PubMed]
  139. Chen, J.; Du, L.; Li, J.; Song, H. Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis. Food Chem. Toxicol. 2016, 96, 70–78. [Google Scholar] [CrossRef] [PubMed]
  140. Liu, E.; Han, L.; Wang, J.; He, W.; Shang, H.; Gao, X.; Wang, T. Eucommia ulmoides bark protects against renal injury in cadmium-challenged rats. J. Med. Food 2012, 15, 307–314. [Google Scholar] [CrossRef] [PubMed]
  141. Elkhadragy, M.F.; Al-Olayan, E.M.; Al-Amiery, A.A.; Abdel Moneim, A.E. Protective effects of fragaria ananassa extract against cadmium chloride-induced acute renal toxicity in rats. Biol. Trace Elem. Res. 2018, 181, 378–387. [Google Scholar] [CrossRef]
  142. Onwuka, F.C.; Erhabor, O.; Eteng, M.U.; Umoh, I.B. Protective effects of ginger toward cadmium-induced testes and kidney lipid peroxidation and hematological impairment in albino rats. J. Med. Food 2011, 14, 817–821. [Google Scholar] [CrossRef]
  143. Veljkovic, A.R.; Nikolic, R.S.; Kocic, G.M.; Pavlovic, D.D.; Cvetkovic, T.P.; Sokolovic, D.T.; Jevtovic, T.M.; Basic, J.T.; Laketic, D.M.; Marinkovic, M.R.; et al. Protective effects of glutathione and lipoic acid against cadmium-induced oxidative stress in rat’s kidney. Ren Fail. 2012, 34, 1281–1287. [Google Scholar] [CrossRef]
  144. Mohamed, N.E. Effect of aqueous extract of glycyrrhiza glabra on the biochemical changes induced by cadmium chloride in rats. Biol. Trace Elem. Res. 2019, 190, 87–94. [Google Scholar] [CrossRef]
  145. Chen, Q.; Zhang, R.; Li, W.M.; Niu, Y.J.; Guo, H.C.; Liu, X.H.; Hou, Y.C.; Zhao, L.J. The protective effect of grape seed procyanidin extract against cadmium-induced renal oxidative damage in mice. Environ. Toxicol. Pharmacol. 2013, 36, 759–768. [Google Scholar] [CrossRef]
  146. Claudio, S.R.; Pidone Ribeiro, F.A.; De Lima, E.C.; Santamarina, A.B.; Pisani, L.P.; Pereira, C.S.D.; Fujiyama Oshima, C.T.; Ribeiro, D.A. The protective effect of grape skin or purple carrot extracts against cadmium intoxication in kidney of rats. Pathophysiology 2019, 26, 263–269. [Google Scholar] [CrossRef] [PubMed]
  147. Winiarska-Mieczan, A. The potential protective effect of green, black, red and white tea infusions against adverse effect of cadmium and lead during chronic exposure—A rat model study. Regul. Toxicol. Pharmacol. 2015, 73, 521–529. [Google Scholar] [CrossRef]
  148. Ranieri, M.; Di Mise, A.; Difonzo, G.; Centrone, M.; Venneri, M.; Pellegrino, T.; Russo, A.; Mastrodonato, M.; Caponio, F.; Valenti, G.; et al. Green olive leaf extract (ole) provides cytoprotection in renal cells exposed to low doses of cadmium. PLoS ONE 2019, 14, e0214159. [Google Scholar] [CrossRef] [PubMed]
  149. Dua, T.K.; Dewanjee, S.; Khanra, R.; Bhattacharya, N.; Bhaskar, B.; Zia-Ul-Haq, M.; De Feo, V. The effects of two common edible herbs, ipomoea aquatica and enhydra fluctuans, on cadmium-induced pathophysiology: A focus on oxidative defence and anti-apoptotic mechanism. J. Transl. Med. 2015, 13, 245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  150. Ojo, O.A.; Ajiboye, B.O.; Oyinloye, B.E.; Ojo, A.B.; Olarewaju, O.I. Protective effect of irvingia gabonensis stem bark extract on cadmium-induced nephrotoxicity in rats. Interdiscip. Toxicol. 2014, 7, 208–214. [Google Scholar] [CrossRef] [Green Version]
  151. Aksoy, N.; Dogan, Y.; Iriadam, M.; Bitiren, M.; Uzer, E.; Ozgonul, A.; Aksoy, S. Protective and therapeutic effects of licorice in rats with acute tubular necrosis. J. Ren. Nutr. 2012, 22, 336–343. [Google Scholar] [CrossRef]
  152. Lan, Z.; Bi, K.S.; Chen, X.H. Ligustrazine attenuates elevated levels of indoxyl sulfate, kidney injury molecule-1 and clusterin in rats exposed to cadmium. Food Chem Toxicol. 2014, 63, 62–68. [Google Scholar] [CrossRef]
  153. Luo, T.; Liu, G.; Long, M.; Yang, J.; Song, R.; Wang, Y.; Yuan, Y.; Bian, J.; Liu, X.; Gu, J.; et al. Treatment of cadmium-induced renal oxidative damage in rats by administration of alpha-lipoic acid. Environ. Sci. Pollut. Res. Int. 2017, 24, 1832–1844. [Google Scholar] [CrossRef]
  154. Suru, S.M. Onion and garlic extracts lessen cadmium-induced nephrotoxicity in rats. Biometals 2008, 21, 623–633. [Google Scholar] [CrossRef]
  155. Shati, A.A. Effects of origanum majorana l. On cadmium induced hepatotoxicity and nephrotoxicity in albino rats. Saudi Med. J. 2011, 32, 797–805. [Google Scholar]
  156. Osukoya, O.A.; Oyinloye, B.E.; Ajiboye, B.O.; Olokode, K.A.; Adeola, H.A. Nephroprotective and anti-inflammatory potential of aqueous extract from persea americana seeds against cadmium-induced nephrotoxicity in wistar rats. Biometals 2021, 34, 1141–1153. [Google Scholar] [CrossRef]
  157. Dkhil, M.A.; Al-Quraishy, S.; Diab, M.M.; Othman, M.S.; Aref, A.M.; Abdel Moneim, A.E. The potential protective role of physalis peruviana l. Fruit in cadmium-induced hepatotoxicity and nephrotoxicity. Food Chem Toxicol. 2014, 74, 98–106. [Google Scholar] [CrossRef]
  158. Yadav, N.; Khandelwal, S. Effect of picroliv on cadmium-induced hepatic and renal damage in the rat. Hum. Exp. Toxicol. 2006, 25, 581–591. [Google Scholar] [CrossRef]
  159. Jung, H.Y.; Seo, D.W.; Hong, C.O.; Kim, J.Y.; Yang, S.Y.; Lee, K.W. Nephroprotection of plantamajoside in rats treated with cadmium. Environ. Toxicol. Pharmacol. 2015, 39, 125–136. [Google Scholar] [CrossRef]
  160. Dkhil, M.A.; Diab, M.S.M.; Lokman, M.S.; El-Sayed, H.; Bauomy, A.A.; Al-Shaebi, E.M.; Al-Quraishy, S. Nephroprotective effect of pleurotus ostreatus extract against cadmium chloride toxicity in rats. An. Acad. Bras. Cienc. 2020, 92, e20191121. [Google Scholar] [CrossRef] [PubMed]
  161. Shen, R.; Liu, D.; Hou, C.; Liu, D.; Zhao, L.; Cheng, J.; Wang, D.; Bai, D. Protective effect of potentilla anserina polysaccharide on cadmium-induced nephrotoxicity in vitro and in vivo. Food Funct. 2017, 8, 3636–3646. [Google Scholar] [CrossRef]
  162. Song, X.B.; Liu, G.; Wang, Z.Y.; Wang, L. Puerarin protects against cadmium-induced proximal tubular cell apoptosis by restoring mitochondrial function. Chem. Biol. Interact. 2016, 260, 219–231. [Google Scholar] [CrossRef] [PubMed]
  163. Alshammari, G.M.; Al-Qahtani, W.H.; AlFaris, N.A.; Albekairi, N.A.; Alqahtani, S.; Eid, R.; Yagoub, A.E.A.; Al-Harbi, L.N.; Yahya, M.A. Quercetin alleviates cadmium chloride-induced renal damage in rats by suppressing endoplasmic reticulum stress through sirt1-dependent deacetylation of xbp-1s and eif2alpha. Biomed. Pharmacother 2021, 141, 111862. [Google Scholar] [CrossRef]
  164. Zhang, Q.; Zhang, C.; Ge, J.; Lv, M.W.; Talukder, M.; Guo, K.; Li, Y.H.; Li, J.L. Ameliorative effects of resveratrol against cadmium-induced nephrotoxicity via modulating nuclear xenobiotic receptor response and pink1/parkin-mediated mitophagy. Food Funct. 2020, 11, 1856–1868. [Google Scholar] [CrossRef] [PubMed]
  165. Ansari, M.N.; Aloliet, R.I.; Ganaie, M.A.; Khan, T.H.; Najeeb Ur, R.; Imam, F.; Hamad, A.M. Roflumilast, a phosphodiesterase 4 inhibitor, attenuates cadmium-induced renal toxicity via modulation of nf-kappab activation and induction of nqo1 in rats. Hum. Exp. Toxicol. 2019, 38, 588–597. [Google Scholar] [CrossRef]
  166. Joardar, S.; Dewanjee, S.; Bhowmick, S.; Dua, T.K.; Das, S.; Saha, A.; De Feo, V. Rosmarinic acid attenuates cadmium-induced nephrotoxicity via inhibition of oxidative stress, apoptosis, inflammation and fibrosis. Int. J. Mol. Sci. 2019, 20, 2027. [Google Scholar] [CrossRef] [Green Version]
  167. Abarikwu, S.O.; Njoku, R.C.; Lawrence, C.J.; Charles, I.A.; Ikewuchi, J.C. Rutin ameliorates oxidative stress and preserves hepatic and renal functions following exposure to cadmium and ethanol. Pharm. Biol. 2017, 55, 2161–2169. [Google Scholar] [CrossRef] [PubMed]
  168. Rashwan, H.M.; Mohammed, H.E.; El-Nekeety, A.A.; Hamza, Z.K.; Abdel-Aziem, S.H.; Hassan, N.S.; Abdel-Wahhab, M.A. Bioactive phytochemicals from salvia officinalis attenuate cadmium-induced oxidative damage and genotoxicity in rats. Environ. Sci. Pollut Res. Int. 2021. [Google Scholar] [CrossRef]
  169. He, L.; Zhang, Q.Q.; Lu, X.Y.; Li, X.X. [effects of water extract of salvia miltiorrhiza aganst renal injury on rats exposed to cadmium]. Zhonghua Yi Xue Za Zhi 2017, 97, 57–61. [Google Scholar] [PubMed]
  170. Albasher, G.; Albrahim, T.; Aljarba, N.; Alharbi, R.I.; Alsultan, N.; Alsaiari, J.; Rizwana, H. Involvement of redox status and the nuclear-related factor 2 in protecting against cadmium-induced renal injury with sana makki (cassia senna l.) pre-treatment in male rats. An. Acad. Bras. Cienc. 2020, 92, e20191237. [Google Scholar] [CrossRef] [PubMed]
  171. Chen, H.; Li, P.; Shen, Z.; Wang, J.; Diao, L. Protective effects of selenium yeast against cadmium-induced necroptosis through mir-26a-5p/pten/pi3k/akt signaling pathway in chicken kidney. Ecotoxicol. Environ. Saf. 2021, 220, 112387. [Google Scholar] [CrossRef]
  172. Bas, H.; Apaydin, F.G.; Kalender, S.; Kalender, Y. Lead nitrate and cadmium chloride induced hepatotoxicity and nephrotoxicity: Protective effects of sesamol on biochemical indices and pathological changes. J. Food Biochem. 2021, 45, e13769. [Google Scholar] [CrossRef]
  173. Ansari, M.A.; Raish, M.; Ahmad, A.; Alkharfy, K.M.; Ahmad, S.F.; Attia, S.M.; Alsaad, A.M.S.; Bakheet, S.A. Sinapic acid ameliorate cadmium-induced nephrotoxicity: In vivo possible involvement of oxidative stress, apoptosis, and inflammation via nf-kappab downregulation. Environ. Toxicol. Pharmacol. 2017, 51, 100–107. [Google Scholar] [CrossRef]
  174. Ramamurthy, C.H.; Subastri, A.; Suyavaran, A.; Subbaiah, K.C.; Valluru, L.; Thirunavukkarasu, C. Solanum torvum swartz. Fruit attenuates cadmium-induced liver and kidney damage through modulation of oxidative stress and glycosylation. Environ. Sci. Pollut. Res. Int. 2016, 23, 7919–7929. [Google Scholar] [CrossRef]
  175. Mzoughi, Z.; Souid, G.; Timoumi, R.; Le Cerf, D.; Majdoub, H. Partial characterization of the edible spinacia oleracea polysaccharides: Cytoprotective and antioxidant potentials against cd induced toxicity in hct116 and hek293 cells. Int. J. Biol. Macromol. 2019, 136, 332–340. [Google Scholar] [CrossRef]
  176. Fouad, A.A.; Jresat, I. Protective effect of telmisartan against cadmium-induced nephrotoxicity in mice. Life Sci. 2011, 89, 29–35. [Google Scholar] [CrossRef]
  177. Mostafa, D.G.; Ahmed, S.F.; Hussein, O.A. Protective effect of tetrahydrobiopterin on hepatic and renal damage after acute cadmium exposure in male rats. Ultrastruct. Pathol. 2018, 42, 516–531. [Google Scholar] [CrossRef] [PubMed]
  178. Junsi, M.; Takahashi Yupanqui, C.; Usawakesmanee, W.; Slusarenko, A.; Siripongvutikorn, S. Thunbergia laurifolia leaf extract increased levels of antioxidant enzymes and protected human cell-lines in vitro against cadmium. Antioxidants 2020, 9, 47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  179. Ansari, M.N.; Rehman, N.U.; Karim, A.; Imam, F.; Hamad, A.M. Protective effect of thymus serrulatus essential oil on cadmium-induced nephrotoxicity in rats, through suppression of oxidative stress and downregulation of nf-kappab, inos, and smad2 mrna expression. Molecules 2021, 26, 1252. [Google Scholar] [CrossRef] [PubMed]
  180. Fouad, A.A.; Alwadaani, H.A.; Jresat, I. Protective effect of thymoquinone against nephrotoxicity induced by cadmium in rats. Intenrational Sch. Sci. Res. Innov. 2016, 10, 73–76. [Google Scholar]
  181. Padma, V.V.; Baskaran, R.; Divya, S.; Priya, L.B.; Saranya, S. Modulatory effect of tinospora cordifolia extract on cd-induced oxidative stress in wistar rats. Integr. Med. Res. 2016, 5, 48–55. [Google Scholar] [CrossRef] [Green Version]
  182. Fan, R.F.; Li, Z.F.; Zhang, D.; Wang, Z.Y. Involvement of nrf2 and mitochondrial apoptotic signaling in trehalose protection against cadmium-induced kidney injury. Metallomics 2020, 12, 2098–2107. [Google Scholar] [CrossRef] [PubMed]
  183. Lakshmi, G.D.; Kumar, P.R.; Bharavi, K.; Annapurna, P.; Rajendar, B.; Patel, P.T.; Kumar, C.S.; Rao, G.S. Protective effect of tribulus terrestris linn on liver and kidney in cadmium intoxicated rats. Indian J. Exp. Biol 2012, 50, 141–146. [Google Scholar]
  184. Ali, S.; Hussain, S.; Khan, R.; Mumtaz, S.; Ashraf, N.; Andleeb, S.; Shakir, H.A.; Tahir, H.M.; Khan, M.K.A.; Ulhaq, M. Renal toxicity of heavy metals (cadmium and mercury) and their amelioration with ascorbic acid in rabbits. Environ. Sci. Pollut. Res. Int. 2019, 26, 3909–3920. [Google Scholar] [CrossRef]
  185. Fang, J.; Xie, S.; Chen, Z.; Wang, F.; Chen, K.; Zuo, Z.; Cui, H.; Guo, H.; Ouyang, P.; Chen, Z.; et al. Protective effect of vitamin e on cadmium-induced renal oxidative damage and apoptosis in rats. Biol. Trace Elem. Res. 2021, 199, 4675–4687. [Google Scholar] [CrossRef]
  186. Yu, J.; Liu, Y.; Guo, J.; Tao, W.; Chen, Y.; Fan, X.; Shen, J.; Duan, J.A. Health risk of licorice-yuanhua combination through induction of colonic h2s metabolism. J. Ethnopharmacol. 2019, 236, 136–146. [Google Scholar] [CrossRef] [PubMed]
  187. Van Cauwenberghe, C.; Vandendriessche, C.; Libert, C.; Vandenbroucke, R.E. Caloric restriction: Beneficial effects on brain aging and alzheimer’s disease. Mamm. Genome 2016, 27, 300–319. [Google Scholar] [CrossRef]
  188. Estrela, G.R.; Wasinski, F.; Batista, R.O.; Hiyane, M.I.; Felizardo, R.J.; Cunha, F.; de Almeida, D.C.; Malheiros, D.M.; Camara, N.O.; Barros, C.C.; et al. Caloric restriction is more efficient than physical exercise to protect from cisplatin nephrotoxicity via ppar-alpha activation. Front. Physiol. 2017, 8, 116. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  189. Sohal, R.S.; Forster, M.J. Caloric restriction and the aging process: A critique. Free Radic. Biol. Med. 2014, 73, 366–382. [Google Scholar] [CrossRef] [Green Version]
  190. Sohal, R.S.; Weindruch, R. Oxidative stress, caloric restriction, and aging. Science 1996, 273, 59–63. [Google Scholar] [CrossRef] [Green Version]
  191. Shaikh, Z.A.; Jordan, S.A.; Tang, W. Protection against chronic cadmium toxicity by caloric restriction. Toxicology 1999, 133, 93–103. [Google Scholar] [CrossRef]
  192. Felley-Bosco, E.; Diezi, J. Dietary calcium restriction enhances cadmium-induced metallothionein synthesis in rats. Toxicol. Lett. 1992, 60, 139–144. [Google Scholar] [CrossRef]
  193. Jin, Z.; Wu, J.; Yan, L.J. Chemical conditioning as an approach to ischemic stroke tolerance: Mitochondria as the target. Int. J. Mol. Sci. 2016, 17, 351. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  194. Wu, J.; Li, R.; Li, W.; Ren, M.; Thangthaeng, N.; Sumien, N.; Liu, R.; Yang, S.; Simpkins, J.W.; Forster, M.J.; et al. Administration of 5-methoxyindole-2-carboxylic acid that potentially targets mitochondrial dihydrolipoamide dehydrogenase confers cerebral preconditioning against ischemic stroke injury. Free Radic. Biol. Med. 2017, 113, 244–254. [Google Scholar] [CrossRef] [Green Version]
  195. Wu, J.; Jin, Z.; Yang, X.; Yan, L.J. Post-ischemic administration of 5-methoxyindole-2-carboxylic acid at the onset of reperfusion affords neuroprotection against stroke injury by preserving mitochondrial function and attenuating oxidative stress. Biochem. Biophys. Res. Commun. 2018, 497, 444–450. [Google Scholar] [CrossRef]
  196. Kim, J.J.; Kim, Y.S.; Kumar, V. Heavy metal toxicity: An update of chelating therapeutic strategies. J. Trace Elem. Med. Biol. 2019, 54, 226–231. [Google Scholar] [PubMed]
  197. Akiyama, M.; Unoki, T.; Shinkai, Y.; Ishii, I.; Ida, T.; Akaike, T.; Yamamoto, M.; Kumagai, Y. Environmental electrophile-mediated toxicity in mice lacking nrf2, cse, or both. Environ. Health Perspect. 2019, 127, 67002. [Google Scholar] [CrossRef] [PubMed]
  198. Shinkai, Y.; Masuda, A.; Akiyama, M.; Xian, M.; Kumagai, Y. Cadmium-mediated activation of the hsp90/hsf1 pathway regulated by reactive persulfides/polysulfides. Toxicol. Sci. 2017, 156, 412–421. [Google Scholar] [PubMed] [Green Version]
  199. Akiyama, M.; Shinkai, Y.; Unoki, T.; Shim, I.; Ishii, I.; Kumagai, Y. The capture of cadmium by reactive polysulfides attenuates cadmium-induced adaptive responses and hepatotoxicity. Chem. Res. Toxicol. 2017, 30, 2209–2217. [Google Scholar] [CrossRef]
  200. Bonventre, J.V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J. Am. Soc. Nephrol. 2003, 14, S55–S61. [Google Scholar] [CrossRef] [Green Version]
  201. Padanilam, B.J. Cell death induced by acute renal injury: A perspective on the contributions of apoptosis and necrosis. Am. J. Physiol. Renal Physiol. 2003, 284, F608–F627. [Google Scholar] [CrossRef] [Green Version]
  202. Chang-Panesso, M.; Humphreys, B.D. Cellular plasticity in kidney injury and repair. Nat. Rev. Nephrol. 2017, 13, 39–46. [Google Scholar] [CrossRef]
  203. Chang-Panesso, M.; Kadyrov, F.F.; Lalli, M.; Wu, H.; Ikeda, S.; Kefaloyianni, E.; Abdelmageed, M.M.; Herrlich, A.; Kobayashi, A.; Humphreys, B.D. Foxm1 drives proximal tubule proliferation during repair from acute ischemic kidney injury. J. Clin. Investig. 2019, 129, 5501–5517. [Google Scholar] [CrossRef]
  204. Moulis, J.M. Cellular mechanisms of cadmium toxicity related to the homeostasis of essential metals. Biometals 2010, 23, 877–896. [Google Scholar] [CrossRef] [PubMed]
  205. Fujiwara, Y.; Lee, J.Y.; Tokumoto, M.; Satoh, M. Cadmium renal toxicity via apoptotic pathways. Biol. Pharm. Bull. 2012, 35, 1892–1897. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Biomolecules 11 01575 g001 550
Figure 1. Diagram showing the proximal convoluted tubule as the major site of cadmium accumulation and toxicity in the nephrons “*”.
Figure 1. Diagram showing the proximal convoluted tubule as the major site of cadmium accumulation and toxicity in the nephrons “*”.
Biomolecules 11 01575 g001
Biomolecules 11 01575 g002 550
Figure 2. Diagram showing mitochondrial electron transport chain and oxidative phosphorylation. Complexes I, II, and III all can generate superoxide anion. This process can be enhanced by pathophysiological conditions such as cadmium exposure and accumulation. Note that it has been suggested that complexes II and III are the likely sites interacting with cadmium [98].
Figure 2. Diagram showing mitochondrial electron transport chain and oxidative phosphorylation. Complexes I, II, and III all can generate superoxide anion. This process can be enhanced by pathophysiological conditions such as cadmium exposure and accumulation. Note that it has been suggested that complexes II and III are the likely sites interacting with cadmium [98].
Biomolecules 11 01575 g002
Biomolecules 11 01575 g003 550
Figure 3. Production of other reactive oxygen species and reactive nitrogen species from the initial species superoxide. Superoxide can be dismutated by superoxide dismutase to form H2O2, which can be further detoxified by catalase. In the presence of metal ions such as iron, H2O2 can also generate very reactive species hydroxyl radical. Additionally, superoxide can react with nitric oxide to form peroxynitrite that is also very reactive toward macromolecules.
Figure 3. Production of other reactive oxygen species and reactive nitrogen species from the initial species superoxide. Superoxide can be dismutated by superoxide dismutase to form H2O2, which can be further detoxified by catalase. In the presence of metal ions such as iron, H2O2 can also generate very reactive species hydroxyl radical. Additionally, superoxide can react with nitric oxide to form peroxynitrite that is also very reactive toward macromolecules.
Biomolecules 11 01575 g003
Biomolecules 11 01575 g004 550
Figure 4. NADPH oxidase assembly and superoxide production at the expense of NADPH. Upon stimulation, each individual subunit of the enzyme is recruited to the membrane and form a membrane-associated complex. Only one subunit GP91 catalyzes partial reduction of oxygen. This figure is adapted from reference [102]. Please not that shown here is NOX2 assembly. For structures and components of other NXO isoforms, please refer reference [103].
Figure 4. NADPH oxidase assembly and superoxide production at the expense of NADPH. Upon stimulation, each individual subunit of the enzyme is recruited to the membrane and form a membrane-associated complex. Only one subunit GP91 catalyzes partial reduction of oxygen. This figure is adapted from reference [102]. Please not that shown here is NOX2 assembly. For structures and components of other NXO isoforms, please refer reference [103].
Biomolecules 11 01575 g004
Biomolecules 11 01575 g005 550
Figure 5. ROS can damage DNA, proteins, and lipids. Damage of the molecules impairs the biological function of each molecule, leading to cell death and kidney injury. Cell death may include both necrosis and apoptosis.
Figure 5. ROS can damage DNA, proteins, and lipids. Damage of the molecules impairs the biological function of each molecule, leading to cell death and kidney injury. Cell death may include both necrosis and apoptosis.
Biomolecules 11 01575 g005
Biomolecules 11 01575 g006 550
Figure 6. Schematic diagram depicting cadmium-induced injury to proximal tubular epithelial cells. When oxidative damage is mild, the cells can mobilize their repair defense system and self-repair, leading to maintenance of cellular function. When oxidative damage is severe, cells lose their self-repair capacity and die, leading to widespread cell death and kidney injury. (Adapted from reference [50]).
Figure 6. Schematic diagram depicting cadmium-induced injury to proximal tubular epithelial cells. When oxidative damage is mild, the cells can mobilize their repair defense system and self-repair, leading to maintenance of cellular function. When oxidative damage is severe, cells lose their self-repair capacity and die, leading to widespread cell death and kidney injury. (Adapted from reference [50]).
Biomolecules 11 01575 g006
Table
Table 1. Counteracting effects of exogenous compounds such as plant extracts, herbs, chemicals and pharmacological agents on cadmium induced renal toxicity.
Table 1. Counteracting effects of exogenous compounds such as plant extracts, herbs, chemicals and pharmacological agents on cadmium induced renal toxicity.
Plant/Extract/ChemicalRodent ModelMechanismReference
Allium hirtifolium boissRatsAnti-oxidative stress[125]
Apple juiceRatsAnti-oxidative stress[126]
Arctium lappaRatsAnti-oxidative stress[127]
Carnosic acidMice and cellsAnti-oxidative damage[128]
CatechinRatsAnti-oxidative damage[129]
Caffeic acid phenethyl esterRatsAnti-oxidative stress[130,131]
Chelidonium majus leavesRatsAntidiuretic[132]
Chorella pyrenoidosaRatsAntihyperglycemic[133]
Cleistocalyx nervosum var. panialaRatsIncreasing antioxidation power[134]
Coriandrum sativum leafMiceAnti-oxidative stress[135]
CurcuminRatsAnti-oxidative stress[136]
EdaravoneMice/CellsInhibiting oxidative stress[137]
ElderberryRatsIncreasing antioxidant enzymes[138]
Epigallocatechin-3-gallateRatsIncreasing antioxidant defense[139]
Eucommia ulmoides barkRatsAnti-oxidative damage[140]
Ferulic acidRatsAnti-oxidative stress[78]
Fragaria ananassaRatsAnti-oxidative stress[141]
GingerRatsDecrease lipid peroxidation[142]
GlutathioneRatsAnti-oxidative stress[143]
Glycyrrhiza glabraRatsAnti-oxidative stress[144]
Grape seed procyanidinMiceAntioxidants[145]
Grape skin/purple carrotRatsAnti-oxidative damage[146]
Green/black/red/white teaRatsAnti-oxidative damage[147]
Green olive leafRenal cells (MCD4) Anti-oxidative stress[148]
Herbal adaptogensChickenAnti-oxidative damage[21]
Ipomoea aquatic/Enhydra fluctuansMiceAnti-oxidation/anti-apoptosis[149]
Irvingia gabonesis stem barkRatsIncreasing antioxidant defense[150]
LicoriceRatsAnti-oxidative damage[151] **
LigustrazineRatsRestoring renal function[152]
Lipoic acidRatsAnti-apoptosis[68,153]
Onion/garlicRatsAnti-oxidative stress[154]
Origanum majorana L.RatsAnti-oxidative damage[155]
Persea americana seedsRatsMitigating oxidative stress [156]
Physalis peruviana LRatsAnti-oxidation/Anti-apoptosis[157]
PicrolivRatsAnti-oxidative stress[158]
PlantamajosideRatsDecrease oxidative damage[159]
Pleurotus ostreatusRats (female)Mitigating oxidative damage[160]
Potentilla anserineMice and cellsAnti-oxidative stress[161]
PuerarinRat proximal tubule cells Restoring mitochondrial function[162]
QuercetinRatsSuppressing ER stress[163]
ResveratrolChickensAnti-oxidative stress[164]
RoflumilastRatsIncreasing antioxidant defense[165]
Rosmarinic acidMiceAnti-oxidative damage[166]
Royal jellyMice (male)Antioxidation/Nrf2 activation[39]
RutinRatsInhibiting oxidative stress[167]
Salvia officinalisRatsAnti-oxidative damage[168]
Salvia miltiorrhizaRatsAnti-oxidative injury[169]
Sana MakkiRatsAnti-oxidative stress/Nrf2[170]
Selenium yeastChickenMitigating necroptosis[171]
SesamolRatsInhibiting oxidative stress[172]
SInapic acidRatsInhibiting oxidative stress[173]
Solanum torvum SwartzRatsAnti-oxidative stress[174]
Spinacia oleracea polysaccharidesHEK293 cellsAnti-oxidative stress[175]
TelmisartanMiceSuppressing oxidative stress[176]
TetrahydrobiopterinRatsMaintaining mitochondria integrity[177]
Thunbergia laurifolia leafKidney cellsIncreasing antioxidant enzymes[178]
Thymus serrulatus essential oilRatsAnti-oxidative stress[179]
ThymoquinoneRatsIncreasing glutathione[180]
Tinospora cordifoliaRatsAnti-oxidative stress[181]
TrehaloseRatsInhibiting oxidative stress[182]
Tribulus terrestris linnRatsAnti-oxidation[183]
Vitamin CRabbitsAnti-oxidative stress[184]
Vitamin ERatsEnhancing antioxidant defense[185]
** Please note that licorice could also pose renal toxicity under certain conditions [186].
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Yan, L.-J.; Allen, D.C. Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism. Biomolecules 2021, 11, 1575. https://doi.org/10.3390/biom11111575

AMA Style

Yan L-J, Allen DC. Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism. Biomolecules. 2021; 11(11):1575. https://doi.org/10.3390/biom11111575

Chicago/Turabian Style

Yan, Liang-Jun, and Daniel C. Allen. 2021. "Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism" Biomolecules 11, no. 11: 1575. https://doi.org/10.3390/biom11111575

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop